Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Time To Focus On GMP Activities Deferred By Pandemic, CDER Compliance Director Says

Sep 20 2022

• By Bowman Cox

Focusing on GMPs — • Source: Shutterstock

Related Content

US FDA's First-Ever Countrywide Import Alert For Drugs Bans Mexican Hand Sanitizers

Jan 29 2021

Chinese Firm Hit With Pandemic's First Remote-Records-Based FDA Drug GMP Warning Letter

Jan 28 2021

US FDA Invites Warning Letter Follow-Up Inspection Alternative Proposals As Pandemic Persists

Jul 01 2020

US FDA Supply Chain Guidance Includes More Stakeholders, More Risks Than CARES Act

May 23 2022

The Quality Lowdown: Wishing Wished-For FDA Re-Inspections Had Gone Better?

Jun 07 2022

Additional Topics

United States International OTC Drugs Manufacturing Regulation Quality Compliance FDA Policy Coronavirus COVID-19 BioPharmaceutical Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window